The Raleigh Street plant sat idle until November 2023, when Georgia-based engineering machinery manufacturer SANY America signed a long-term lease on the property. Vertex had never owned the site, ...

One positive sign was that Vertex raised the lower end of its forecast for full-year 2025 revenue by $100 million. The ...

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 13 cents per share. The company posted revenue of $177.1 ...

Q1 2025 Management View CEO David DeStefano highlighted Vertex's strong start to 2025, reporting $177.1 million in revenue, a ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

William Blair just gave Vertex Pharmaceuticals a shiny bump in its 2025 earnings forecast, increasing EPS to $16.20 from ...

Vertex Pharmaceuticals took a confidence hit as Leerink Partners downgraded the stock from “strong-buy” to a mere “hold,” ...